Conclusions In the SURPASS-2 trial in people with T2D inadequately controlled on metformin monotherapy, once-weekly tirzepatide, a dual GIP/GLP-1 receptor agonist, demonstrated 4 : Superior and clinically meaningful improvements in glycemic control
Moreover, MSG inhibits the production of germ cells, subsequently reducing the number of spermatogonia, spermatocytes, and spermatids and leading to oligospermia in the testicular tissue by affecting DNA molecules [60]
Si han pasado ms de 2 semanas desde tu ltima dosis , debes contactar con tu mdico, ya que es probable que necesites reiniciar el tratamiento con la dosis ms baja de 0,25 mg por semana
For instance, GLP-1s are designed to suppress appetite
Its important to remember that weight loss is a gradual process, and combining these medications with a balanced diet and regular exercise will help you achieve the best long-term results